Epiclos 0.50ml Injection
Marketer
Quepreon Biologicals Pvt Ltd
Salt Composition
n-Butyl-2-cyanoacrylate (0.50ml)
Overview Epiclos 0.50ml Injection
Hemostatic solution Epiclos (0.50ml injection) is indicated for hemorrhage management. Functioning as a tissue sealant, Epiclos requires administration by a qualified healthcare provider. Prior to use, report any allergies to this medication. Disclose all current medications, pregnancy status, breastfeeding, and any significant liver, cardiac, or renal impairment to your physician. Adverse reactions are uncommon.
Uses of Epiclos 0.50ml Injection
Hemorrhage
Major Benefits of Epiclos 0.50ml Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Epiclos 0.50ml Injection:
- No common side effects seen
How to use Epiclos 0.50ml Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Epiclos 0.50ml Injection works:
Surgical-grade Epiclos 0.50ml Injection is a liquid tissue sealant. Its rapid-setting formulation creates a robust bond at the wound site, effectively hemostasing and facilitating rapid tissue approximation for optimal healing.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Epiclos 0.50ml Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the administration of 0.50ml Epiclos Injection to pregnant individuals is absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Epiclos 0.50ml Injection with breastfeeding are unavailable. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Epiclos 0.50ml Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Epiclos 0.50ml Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Epiclos 0.50ml Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Epiclos 0.50ml Injection :
Omit a dose of Epiclos 0.50ml Injection? Seek medical advice.
Facts to Know About Epiclos 0.50ml Injection
| Label | Value |
|---|---|
| Chemical Type | Cyanoacrylate-based compound |
| Developing Habits | No. |
| Treatment Category | Alternatives |
| Action Class | Blood clotting agent |
3,018 People bought this recently